- Home
- ILAG vs BGLC Comparison
ILAG vs BGLC Comparison
Compare ILAG & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILAG
- BGLC
- Stock Information
- Founded
- ILAG 1981
- BGLC 2017
- Country
- ILAG Hong Kong
- BGLC Malaysia
- Employees
- ILAG N/A
- BGLC N/A
- Industry
- ILAG Office Equipment/Supplies/Services
- BGLC Medical Specialities
- Sector
- ILAG Consumer Discretionary
- BGLC Health Care
- Exchange
- ILAG Nasdaq
- BGLC Nasdaq
- Market Cap
- ILAG 18.4M
- BGLC 7.6M
- IPO Year
- ILAG 2022
- BGLC N/A
- Fundamental
- Price
- ILAG $0.98
- BGLC $0.38
- Analyst Decision
- ILAG
- BGLC
- Analyst Count
- ILAG 0
- BGLC 0
- Target Price
- ILAG N/A
- BGLC N/A
- AVG Volume (30 Days)
- ILAG 47.1K
- BGLC 116.1K
- Earning Date
- ILAG 11-29-2024
- BGLC 11-20-2024
- Dividend Yield
- ILAG N/A
- BGLC N/A
- EPS Growth
- ILAG N/A
- BGLC N/A
- EPS
- ILAG N/A
- BGLC N/A
- Revenue
- ILAG $6,443,357.00
- BGLC $9,183,168.00
- Revenue This Year
- ILAG N/A
- BGLC N/A
- Revenue Next Year
- ILAG N/A
- BGLC N/A
- P/E Ratio
- ILAG N/A
- BGLC N/A
- Revenue Growth
- ILAG N/A
- BGLC N/A
- 52 Week Low
- ILAG $0.33
- BGLC $0.31
- 52 Week High
- ILAG $1.35
- BGLC $3.39
- Technical
- Relative Strength Index (RSI)
- ILAG 44.56
- BGLC 41.00
- Support Level
- ILAG $0.97
- BGLC $0.38
- Resistance Level
- ILAG $1.06
- BGLC $0.49
- Average True Range (ATR)
- ILAG 0.06
- BGLC 0.02
- MACD
- ILAG -0.01
- BGLC -0.00
- Stochastic Oscillator
- ILAG 16.32
- BGLC 32.66
About ILAG Intelligent Living Application Group Inc.
Intelligent Living Application Group Inc is engaged in the business of manufacturing and selling mechanical locksets. The business is spread across the Unites States, Canada, Australia, and China. Majority of the revenue is generated from the United States.
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.